Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...
14don MSN
Roche says experimental drug helped slow disability in progressive multiple sclerosis study
Roche Holdings AG RHHBY on Monday shared new late-breaking data from the Phase 3 FENtrepid study of the investigational ...
About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.
Cognitive health is not only the absence of cognitive impairment. It's the ability to maintain mental efficiency, flexibility, and emotional balance despite the burden of the disease. Cognitive ...
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50 years of patient treatment Overall safety profile of BRIUMVI remained ...
New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.
Multiple sclerosis affects your abilities and the way your body functions, and this sometimes includes sexual function. Damage to the brain and spinal cord in MS can contribute to erectile dysfunction ...
—Using CDC data, researchers in Pakistan have found that annual age-adjusted mortality rates due to multiple sclerosis in the U.S. rose between 1999 and 2020, a trend that was observed across both ...
Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system, including the brain, spinal cord, and optic nerves. The body mistakenly attacks and damages the protective ...
Nearly 1 million people in the United States have MS, and there’s a thriving community of like-minded people dedicated to finding a cure and helping people live their best life while managing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results